Gapdh mab

Manufactured by Abcam

Sourced in United States

GAPDH mAb is a mouse monoclonal antibody that recognizes the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein. GAPDH is a key enzyme involved in glycolysis and is widely used as a loading control in Western blotting and other protein analysis techniques.

Automatically generated - may contain errors

Lab products found in correlation

Jnj 38877605, by Selleck Chemicals (1 mentions) Rapamycin rapa, by Selleck Chemicals (1 mentions) Anti human igg4, by Abcam (1 mentions) Actin hrp, by Merck Group (1 mentions) Mab flag, by Merck Group (1 mentions)

Spelling variants of this product

GAPDH (2872 citations) MAb anti‐GAPDH (4 citations) Rabbit anti-GAPDH mAbs (2 citations) Gapdh Rabbit mAb (2 citations) GAPDH mouse mAb (2 citations)

2 protocols using gapdh mab

HGF and c-MET Inhibitor Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

Human recombinant HGF was purchased from GenScript (Nanjing, China). The c-MET kinase inhibitors JNJ38877605 and rapamycin (RAPA) were obtained from Selleckchem (Houston, TX). Antibodies used include c-MET mAb, p-MET (Tyr^1234/1235) mAb, Notch mAb, HES-1 mAb, and GAPDH mAb. Antibodies used in this study include c-MET mAb, p-MET (Tyr1234/1235) mAb (Abcam, U.S.A.), Notch mAb (Abcam, U.S.A.), HES-1 mAb (Abcam, U.S.A.), GAPDH mAb (Abcam, U.S.A.), Anti-mouse IgG (Abcam, U.S.A.), anti-CTLA4, #EPR1476 (Abcam, U.S.A.) and anti-human IgG4(Abcam, U.S.A.). All antibodies were purchased from Cell Signaling Technology, Inc.

Li J.F., Niu Y.Y., Xing Y.L, & Liu F. (2019). A novel bispecific c-MET/CTLA-4 antibody targetting lung cancer stem cell-like cells with therapeutic potential in human non-small-cell lung cancer. Bioscience Reports, 39(5), BSR20171278.

+ Open protocol

+ Expand

Antibody Panel for Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

Several antibodies were used throughout this study: pan 14-3-3 pAb (Santa Cruz, K19 sc-629), K8 mAb (DSHB, 1h5), C-Cadherin mAb (DSHB, 6B6), pan Cadherin pAb (Santa Cruz, H-300 sc-10733), Vinculin mAb (Millipore, MAB3574), K19 mAb (Progen, 61010), pan keratin mAb (Sigma Aldrich, C2562), Actin-HRP (Sigma-Aldrich,A3854), GAPDH mAb (Abcam, mAbcam 9484), GFP mAb (Invitrogen, A-11120), GFP mAb (Santa Cruz, B-2 sc-9996), mCherry pAb (BioVision, 5993-100), and FLAG mAb (Sigma-Aldrich, F1804). The 1h5 anti-XCK1(8) monoclonal antibody developed by Michael Klymkowsky and 6B6 anti-C-cadherin monoclonal antibody developed by Barry Gumbiner were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the Department of Biology, University of Iowa (Iowa City, IA 52242).

Mariani R.A., Paranjpe S., Dobrowolski R, & Weber G.F. (2020). 14-3-3 targets keratin intermediate filaments to mechanically sensitive cell–cell contacts. Molecular Biology of the Cell, 31(9), 930-943.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!